Image de couverture de livre

Mapping Molecular Diversity in Prostate Cancer With a Combined Multiplex IHC and RNA‐ISH Assay

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shannon Carskadon, Sean Williamson, Sangeetha Jyothilingam, Nilesh Gupta, Nallasivam Palanisamy
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cover Image: Volume 86 Issue 4
par: Shannon Carskadon, et autres
Publié: (2026)

Cover Image: Volume 85 Issue 13
par: Ishvaria Sundaresan, et autres
Publié: (2025)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
par: Mark Kidd, et autres
Publié: (2025)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
par: Y. M. Yáñez‐Castillo, et autres
Publié: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
par: Elizabeth Robinson, et autres
Publié: (2025)

miRNAs Regulating GSTP1 as Potential Diagnostic Biomarkers in Prostate Cancer
par: Shiv Verma, et autres
Publié: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
par: Yuto Ono, et autres
Publié: (2025)

Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA Hydroxymethylation in a Mouse Model of Prostate Cancer
par: Matthew Aguilera, et autres
Publié: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
par: Tatsuya Shimomura, et autres
Publié: (2026)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
par: AhmadReza Rezaeian, et autres
Publié: (2026)

Evidence and Rationale for Prostate Cancer Screening
par: Takeshi Takahashi
Publié: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
par: Hannu Koistinen, et autres
Publié: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
par: Sheila Jonnatan, et autres
Publié: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
par: Andrea K. Miyahira, et autres
Publié: (2024)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
par: Yifu Shi, et autres
Publié: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
par: Reid Vassallo, et autres
Publié: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
par: Erum Z. Whyne, et autres
Publié: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
par: Charly Bâcle, et autres
Publié: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
par: Haotian Chen, et autres
Publié: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
par: Christian P. Pavlovich, et autres
Publié: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
par: Kristofer G. Taylor, et autres
Publié: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
par: Muhammad Umair, et autres
Publié: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
par: Christian Andrés Martínez Osorio, et autres
Publié: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
par: Cameron J. Britton, et autres
Publié: (2025)

Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer
par: Jun Lu, et autres
Publié: (2026)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
par: Trevor C. Hunt, et autres
Publié: (2025)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
par: Marta Victoria Lorenzo‐Sánchez, et autres
Publié: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
par: Yu‐Hsiang Lin, et autres
Publié: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
par: Anwar E. Ahmed, et autres
Publié: (2025)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
par: Anna‐Lena Lemster, et autres
Publié: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
par: Andrea K. Miyahira, et autres
Publié: (2024)

Microbial Differences in Prostate Lesions Between Black and White American Men
par: Shiv Verma, et autres
Publié: (2026)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
par: Fabian Falkenbach, et autres
Publié: (2025)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
par: Toshifumi Takahashi, et autres
Publié: (2024)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
par: Liza M. Kurucz, et autres
Publié: (2025)

Survival Outcomes for Rural Patients With Advanced Prostate Cancer: A SEER Investigation
par: Liang G. Qu, et autres
Publié: (2025)

Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
par: Trevor C. Hunt, et autres
Publié: (2025)

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy
par: Isabella Gruber, et autres
Publié: (2025)

Genetics‐Driven, Intensity‐Modulated Adaptive Management of Patients With Metastatic Prostate Cancer
par: Reynier D. Rodriguez Rosales, et autres
Publié: (2025)

Second Therapeutic Freeze After Salvage Cryoablation for Localized Radiorecurrent Prostate Cancer
par: Sudharshanan Balaji, et autres
Publié: (2026)